LYMPHOKINE ACTIVATED KILLER-CELL AND INTERLEUKIN-2 INHIBITORS - THEIR ROLE IN ADOPTIVE IMMUNOTHERAPY

被引：0
|
作者：
EGGERMONT, AMM [1 ]
SUGARBAKER, PH [1 ]
机构：
[1] NCI,BETHESDA,MD 20892
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1987年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：363 / 363
页数：1
相关论文
共 50 条
  • [41] TREATMENT WITH LYMPHOKINE-ACTIVATED KILLER CELLS AND INTERLEUKIN-2
    DEGOS, L
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1988, 30 (1-2): : 119 - 122
  • [42] INFLUENCE OF SCHEDULE OF INTERLEUKIN-2 ADMINISTRATION ON THERAPY WITH INTERLEUKIN-2 AND LYMPHOKINE ACTIVATED KILLER CELLS
    THOMPSON, JA
    LEE, DJ
    LINDGREN, CG
    BENZ, LA
    COLLINS, C
    SHUMAN, WP
    LEVITT, D
    FEFER, A
    CANCER RESEARCH, 1989, 49 (01) : 235 - 240
  • [43] ADOPTIVE IMMUNOTHERAPY USING LYMPHOKINE-ACTIVATED KILLER CELLS
    FOWLER, JE
    JOURNAL OF UROLOGY, 1988, 139 (01): : 148 - 149
  • [44] ADOPTIVE IMMUNOTHERAPY OF HUMAN PANCREATIC-CANCER WITH LYMPHOKINE-ACTIVATED KILLER-CELLS AND INTERLEUKIN-2 IN A NUDE-MOUSE MODEL
    MARINCOLA, FM
    DAPOZZO, LF
    DRUCKER, BJ
    HOLDER, WD
    SURGERY, 1990, 108 (05) : 919 - 929
  • [45] PROLONGED CONTINUOUS INTRAVENOUS-INFUSION INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELL THERAPY FOR METASTATIC RENAL-CELL CARCINOMA
    THOMPSON, JA
    SHULMAN, KL
    BENYUNES, MC
    LINDGREN, CG
    COLLINS, C
    LANGE, PH
    BUSH, WH
    BENZ, LA
    FEFER, A
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (06) : 960 - 968
  • [46] LOCAL ADOPTIVE IMMUNOTHERAPY USING LYMPHOKINE-ACTIVATED KILLER-CELLS AND INTERLEUKIN-2 AGAINST MALIGNANT PLEURAL MESOTHELIOMA - REPORT OF 2 CASES
    YANAGAWA, H
    SONE, S
    FUKUTA, K
    NISHIOKA, Y
    OGURA, T
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1991, 21 (05) : 377 - 383
  • [47] INVIVO BOOSTING OF LUNG NATURAL-KILLER AND LYMPHOKINE-ACTIVATED KILLER-CELL ACTIVITY BY INTERLEUKIN-2 - COMPARISON OF SYSTEMIC, INTRAPLEURAL AND INHALATION ROUTES
    FLEXMAN, JP
    MANNING, LS
    ROBINSON, BWS
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1990, 82 (01): : 151 - 156
  • [48] AUGMENTATION OF INSULIN AUTOANTIBODIES FOLLOWING INTERLEUKIN-2 AND LYMPHOKINE ACTIVATED KILLER CELL THERAPY
    BERGSTROM, RW
    ATKINS, MB
    PALMER, JP
    CLINICAL RESEARCH, 1990, 38 (01): : A118 - A118
  • [49] THE SYSTEMIC COMPLEMENT ACTIVATION CAUSED BY INTERLEUKIN-2/LYMPHOKINE ACTIVATED KILLER-CELL THERAPY OF CANCER CAUSES MINIMAL SYSTEMIC NEUTROPHIL ACTIVATION
    SCHOOF, DD
    MOORE, FD
    RODRICK, M
    EBERLEIN, TJ
    FASEB JOURNAL, 1991, 5 (06): : A1772 - A1772
  • [50] INTERLEUKIN-2 THERAPY WITH OR WITHOUT LYMPHOKINE-ACTIVATED KILLER-CELL INFUSIONS FOR LOW-GRADE NON-HODGKINS-LYMPHOMAS
    LEVY, R
    TOURANI, JM
    ANDRIEU, JM
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (08) : 1366 - 1366
12345